Unlocking therapeutic potential: the role of adamantane in drug discovery
Field | Value | Language |
dc.contributor.author | Dane, Chianna | |
dc.contributor.author | Cumbers, Grace A. | |
dc.contributor.author | Allen, Beau | |
dc.contributor.author | Montgomery, Andrew P. | |
dc.contributor.author | Danon, Jonathan J. | |
dc.contributor.author | Kassiou, Michael | |
dc.date.accessioned | 2024-08-30T05:40:21Z | |
dc.date.available | 2024-08-30T05:40:21Z | |
dc.date.issued | 2024 | en_AU |
dc.identifier.uri | https://hdl.handle.net/2123/33036 | |
dc.description.abstract | The unique structural and physicochemical properties of adamantane and its derivatives have attracted considerable attention in the field of medicinal chemistry. Substituting phenyl rings for adamantane or its derivatives has provided a promising strategy to introduce lipophilicity and escape the ‘flat land’ of modern drug discovery. Additionally, the unique three-dimensional structure of adamantane facilitates the precise positioning of substituents allowing for a more effective exploration of drug targets. Evidently, we have seen an increased use of adamantane in pharmaceutically relevant molecules. The following Account highlights our group’s research in five drug discovery programs over the past 15 years showcasing the use of adamantane and its analogues in these studies. | en_AU |
dc.language.iso | en | en_AU |
dc.publisher | CSIRO Publishing | en_AU |
dc.relation.ispartof | Australian Journal of Chemistry | en_AU |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 | en_AU |
dc.subject | adamantane | en_AU |
dc.subject | cannabinoid receptors | en_AU |
dc.subject | CNS | en_AU |
dc.subject | medicinal chemistry | en_AU |
dc.subject | NMDA receptor | en_AU |
dc.subject | P2X7 receptor | en_AU |
dc.subject | sigma-2 receptor | en_AU |
dc.subject | structure–activity relationships | en_AU |
dc.subject | tau aggregation | en_AU |
dc.title | Unlocking therapeutic potential: the role of adamantane in drug discovery | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.1071/CH24075 | |
dc.type.pubtype | Publisher's version | en_AU |
dc.rights.other | © 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing. This is an open access article distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) | en_AU |
dc.relation.other | The work presented herein was supported by the Australian Research Council and the National Health and Medical Research Council. | |
usyd.faculty | SeS faculties schools::Faculty of Science::School of Chemistry | en_AU |
usyd.citation.volume | 77 | en_AU |
usyd.citation.issue | 8 | en_AU |
usyd.citation.spage | 1 | en_AU |
usyd.citation.epage | 16 | en_AU |
workflow.metadata.only | No | en_AU |
Associated file/s
Associated collections